199 related articles for article (PubMed ID: 29755103)
21. Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
Friedel G; Budach W; Dippon J; Spengler W; Eschmann SM; Pfannenberg C; Al-Kamash F; Walles T; Aebert H; Kyriss T; Veit S; Kimmich M; Bamberg M; Kohlhaeufl M; Steger V; Hehr T
J Clin Oncol; 2010 Feb; 28(6):942-8. PubMed ID: 20100967
[TBL] [Abstract][Full Text] [Related]
22. A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903).
Katakami N; Tada H; Mitsudomi T; Kudoh S; Senba H; Matsui K; Saka H; Kurata T; Nishimura Y; Fukuoka M
Cancer; 2012 Dec; 118(24):6126-35. PubMed ID: 22674529
[TBL] [Abstract][Full Text] [Related]
23. Trimodality vs Chemoradiation and Salvage Resection in cN2 Stage IIIA Non-Small Cell Lung Cancer.
Ye JC; Ding L; Atay SM; Nieva JJ; McFadden PM; Chang E; Kim AW
Semin Thorac Cardiovasc Surg; 2020; 32(1):153-159. PubMed ID: 31220530
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of anti-PD-1 therapy for recurrence after chemoradiotherapy in locally advanced NSC LC.
Amino Y; Kitazono S; Uematsu S; Hasegawa T; Yoshizawa T; Uchibori K; Yanagitani N; Horiike A; Horai T; Kasahara K; Nishio M
Int J Clin Oncol; 2020 Jan; 25(1):67-73. PubMed ID: 31506751
[TBL] [Abstract][Full Text] [Related]
25. Induction chemoradiotherapy versus chemotherapy alone for superior sulcus lung cancer.
Robinson LA; Tanvetyanon T; Grubbs D; Antonia S; Creelan B; Fontaine J; Toloza E; Keenan R; Dilling T; Stevens CW; Sommers KE; Vrionis F
Lung Cancer; 2018 Aug; 122():206-213. PubMed ID: 30032833
[TBL] [Abstract][Full Text] [Related]
26. Is pneumonectomy justifiable for patients with a locoregional recurrence or persistent disease after curative intent chemoradiotherapy for locally advanced non-small cell lung cancer?
Joosten PJM; Dickhoff C; van der Noort V; Klomp HM; van Diessen JNA; Dahele M; Bahce I; Veenhof AAFA; Smit EF; Hartemink KJ
Lung Cancer; 2020 Dec; 150():209-215. PubMed ID: 33220611
[TBL] [Abstract][Full Text] [Related]
27. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
[TBL] [Abstract][Full Text] [Related]
28. Salvage Surgery Compared to Surgery After Induction Chemoradiation Therapy for Advanced Lung Cancer.
Kobayashi AK; Nakagawa K; Nakayama Y; Ohe Y; Yotsukura M; Uchida S; Asakura K; Yoshida Y; Watanabe SI
Ann Thorac Surg; 2022 Dec; 114(6):2087-2092. PubMed ID: 34843695
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy.
Morita M; Kumashiro R; Hisamatsu Y; Nakanishi R; Egashira A; Saeki H; Oki E; Ohga T; Kakeji Y; Tsujitani S; Yamanaka T; Maehara Y
J Gastroenterol; 2011 Nov; 46(11):1284-91. PubMed ID: 21818602
[TBL] [Abstract][Full Text] [Related]
30. [Induction Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer].
Miura A; Soh J; Shien K; Yamamoto H; Toyooka S
Kyobu Geka; 2018 Apr; 71(4):270-277. PubMed ID: 29755100
[TBL] [Abstract][Full Text] [Related]
31. Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer.
Taugner J; Eze C; Käsmann L; Roengvoraphoj O; Gennen K; Karin M; Petrukhnov O; Tufman A; Belka C; Manapov F
Radiat Oncol; 2020 Jun; 15(1):148. PubMed ID: 32517716
[TBL] [Abstract][Full Text] [Related]
32. Salvage Surgery After Chemotherapy or Chemoradiotherapy for Initially Unresectable Lung Carcinoma.
Sonobe M; Yutaka Y; Nakajima D; Hamaji M; Menju T; Ohsumi A; Chen-Yoshikawa TF; Sato T; Date H
Ann Thorac Surg; 2019 Dec; 108(6):1664-1670. PubMed ID: 31445048
[TBL] [Abstract][Full Text] [Related]
33. Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chemoradiotherapy for stage IB, II, and III esophageal squamous cell cancer.
Makazu M; Kato K; Takisawa H; Yoshinaga S; Oda I; Saito Y; Mayahara H; Ito Y; Itami J; Hamaguchi T; Yamada Y; Shimada Y
Dis Esophagus; 2014 Jan; 27(1):42-9. PubMed ID: 23442160
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor receptor mutation is associated with longer local control after definitive chemoradiotherapy in patients with stage III nonsquamous non-small-cell lung cancer.
Yagishita S; Horinouchi H; Katsui Taniyama T; Nakamichi S; Kitazono S; Mizugaki H; Kanda S; Fujiwara Y; Nokihara H; Yamamoto N; Sumi M; Shiraishi K; Kohno T; Furuta K; Tsuta K; Tamura T
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):140-8. PubMed ID: 25442336
[TBL] [Abstract][Full Text] [Related]
35. Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial.
Pöttgen C; Eberhardt WE; Gauler T; Krbek T; Berkovic K; Jawad JA; Korfee S; Teschler H; Stamatis G; Stuschke M
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):809-15. PubMed ID: 19427744
[TBL] [Abstract][Full Text] [Related]
36. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
[TBL] [Abstract][Full Text] [Related]
37. Salvage surgery for locoregional recurrence or persistent tumor after high dose chemoradiotherapy for locally advanced non-small cell lung cancer.
Dickhoff C; Dahele M; Paul MA; van de Ven PM; de Langen AJ; Senan S; Smit EF; Hartemink KJ
Lung Cancer; 2016 Apr; 94():108-13. PubMed ID: 26973215
[TBL] [Abstract][Full Text] [Related]
38. Preoperative concurrent chemoradiotherapy followed by extrapleural pneumonectomy for patients with non-small cell lung cancer with malignant pleural effusion and/or pleural nodules: Ten-year results of a prematurely terminated single institute phase II trial.
Yamaguchi M; Ichinose Y; Shimamatsu S; Yoshida T; Toyokawa G; Nosaki K; Hirai F; Seto T; Takenoyama M
Surg Oncol; 2015 Jun; 24(2):78-83. PubMed ID: 25818753
[TBL] [Abstract][Full Text] [Related]
39. Salvage Lung Resections After Definitive Chemoradiotherapy: A Safe and Effective Oncologic Option.
Bograd AJ; Mann C; Gorden JA; Gilbert CR; Farivar AS; Aye RW; Louie BE; Vallières E
Ann Thorac Surg; 2020 Oct; 110(4):1123-1130. PubMed ID: 32473131
[TBL] [Abstract][Full Text] [Related]
40. Long-term oncological and functional outcomes of induction chemotherapy followed by (chemo)radiotherapy vs definitive chemoradiotherapy vs surgery-based therapy in locally advanced stage III/IV hypopharyngeal cancer: Multicenter review of 266 cases.
Chung EJ; Jeong WJ; Jung YH; Kwon SK; Kwon TK; Ahn SH; Sung MW; Keam B; Heo DS; Kim JH; Wu HG; Lee KW; Eom KY; Rho YS
Oral Oncol; 2019 Feb; 89():84-94. PubMed ID: 30732965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
